Why Did Buffett Sell the S&P 500?
Warren Buffett has always been an advocate of investing in…
Sell
23
EDOC Quote, Financials, Valuation and Earnings
Last price:
$9.40
Seasonality move
:
-4.7%
Day range:
$9.35 - $9.57
52-week range:
$8.41 - $11.91
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.6K
Avg. volume:
38.7K
1-year change:
-1.37%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
$9.38 | -- | -- | -- | $0.00 | 0% | -- |
|
AGNG
Global X Aging Population ETF
|
$31.25 | -- | -- | -- | $0.15 | 0.8% | -- |
|
CANC
Tema Oncology ETF
|
$24.53 | -- | -- | -- | $0.73 | 2.04% | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
$8.35 | -- | -- | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | 1.921 | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | 0.954 | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | 1.116 | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | 2.063 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
EDOC
Global X Telemedicine & Digital Health ETF
|
-- | -- | -- | -- | -- | -- |
|
AGNG
Global X Aging Population ETF
|
-- | -- | -- | -- | -- | -- |
|
CANC
Tema Oncology ETF
|
-- | -- | -- | -- | -- | -- |
|
GNOM
Global X Genomics & Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
Global X Telemedicine & Digital Health ETF vs. Competitors
-
Which has Higher Returns EDOC or AGNG?
Global X Aging Population ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Aging Population ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- AGNGGlobal X Aging Population ETF-- -- -- -
What do Analysts Say About EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Aging Population ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Aging Population ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Aging Population ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 AGNGGlobal X Aging Population ETF0 0 0 -
Is EDOC or AGNG More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Aging Population ETF has a beta of 0.797, suggesting its less volatile than the S&P 500 by 20.348%.
-
Which is a Better Dividend Stock EDOC or AGNG?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Aging Population ETF offers a yield of 0.8% to investors and pays a quarterly dividend of $0.15 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Aging Population ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or AGNG?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Aging Population ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Aging Population ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Aging Population ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Aging Population ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- AGNGGlobal X Aging Population ETF-- -- -- --
-
Which has Higher Returns EDOC or CANC?
Tema Oncology ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Tema Oncology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- CANCTema Oncology ETF-- -- -- -
What do Analysts Say About EDOC or CANC?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Tema Oncology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Tema Oncology ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Tema Oncology ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 CANCTema Oncology ETF0 0 0 -
Is EDOC or CANC More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Tema Oncology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock EDOC or CANC?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Tema Oncology ETF offers a yield of 2.04% to investors and pays a quarterly dividend of $0.73 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Tema Oncology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or CANC?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Tema Oncology ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Tema Oncology ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Tema Oncology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Tema Oncology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- CANCTema Oncology ETF-- -- -- --
-
Which has Higher Returns EDOC or GNOM?
Global X Genomics & Biotechnology ETF has a net margin of -- compared to Global X Telemedicine & Digital Health ETF's net margin of --. Global X Telemedicine & Digital Health ETF's return on equity of -- beat Global X Genomics & Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- -
What do Analysts Say About EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Global X Genomics & Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Global X Telemedicine & Digital Health ETF has higher upside potential than Global X Genomics & Biotechnology ETF, analysts believe Global X Telemedicine & Digital Health ETF is more attractive than Global X Genomics & Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings EDOCGlobal X Telemedicine & Digital Health ETF0 0 0 GNOMGlobal X Genomics & Biotechnology ETF0 0 0 -
Is EDOC or GNOM More Risky?
Global X Telemedicine & Digital Health ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Global X Genomics & Biotechnology ETF has a beta of 1.215, suggesting its more volatile than the S&P 500 by 21.496%.
-
Which is a Better Dividend Stock EDOC or GNOM?
Global X Telemedicine & Digital Health ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Global X Genomics & Biotechnology ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Global X Telemedicine & Digital Health ETF pays -- of its earnings as a dividend. Global X Genomics & Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios EDOC or GNOM?
Global X Telemedicine & Digital Health ETF quarterly revenues are --, which are smaller than Global X Genomics & Biotechnology ETF quarterly revenues of --. Global X Telemedicine & Digital Health ETF's net income of -- is lower than Global X Genomics & Biotechnology ETF's net income of --. Notably, Global X Telemedicine & Digital Health ETF's price-to-earnings ratio is -- while Global X Genomics & Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Global X Telemedicine & Digital Health ETF is -- versus -- for Global X Genomics & Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income EDOCGlobal X Telemedicine & Digital Health ETF-- -- -- -- GNOMGlobal X Genomics & Biotechnology ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will SoundHound AI Stock Recover?
SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…
What Stocks Did Warren Buffett Just Buy?
In Q4 of last year, Warren Buffett added to or…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 36x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
41
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
78
AJINY alert for Mar 29
Ajinomoto [AJINY] is up 99.61% over the past day.
Buy
69
AGX alert for Mar 29
Argan [AGX] is up 19.83% over the past day.
Sell
24
AIR alert for Mar 29
AAR [AIR] is down 16.36% over the past day.
